On February 21, 2024, Adverum Biotechnologies, Inc. closed the transaction.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.33 USD | -0.27% | -6.32% | -3.56% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.56% | 153M | |
+17.98% | 125B | |
+13.30% | 108B | |
-6.86% | 24.21B | |
+0.26% | 22.78B | |
-11.16% | 17.96B | |
-41.74% | 16.43B | |
-13.98% | 16.37B | |
+1.32% | 13.58B | |
+28.35% | 11.66B |
- Stock Market
- Equities
- ADVM Stock
- News Adverum Biotechnologies, Inc.
- Adverum Biotechnologies, Inc. announced that it has received $127.5 million in funding from a group of investors